News more

  • Foley Hoag Congratulates OwnerIQ for Closing Series B Round  [Read More]
  • Live @ BIO 2008: Innovation, Commercialization, and Protecting Assets  [Read More]
  • Chambers USA 2008 Ranks Foley Hoag in Leading Practice Areas  [Read More]
  • Foley Hoag's M&A, Venture Capital Practices Lauded by Legal 500  [Read More]
  • Bio International Convention. The global event for biotechnology.
    Foley Hoag Launches Second Annual "Terms and Trends in Patent License Agreements" Survey  [Read More]

Publications more

  • Pension and Disability Plan’s Eligibility Rules Did Not Violate the ADEA [Read More]
  • Recent Supreme Court Decision Establishes Greater Scrutiny of Benefits Determinations by Employers with Dual Role of Making Benefits Determinations and Paying Out Benefits [Read More]
  • House Passes Legislation That Would Increase the Taxation of Carried Interest Income [Read More]
  • Five Common Employment Law Hazards for Start-Ups [Read More]
  • Follow-on Biologics and Patent Reform [Read More]
  • Life Sciences: Government Strategies Data Sheet [Read More]

Events more

July 9, 2008 The Missing Piece in Climate Policy [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
September 6, 2008 AIPPI's 41st World Intellectual Property Congress  [Read More] Boston Convention and Exhibition Center
Boston, MA

Client Successes

  • Foley Hoag Clears Way for Senior Financial Services Executive
    In one of the few decisions in the country on the enforceability of “garden leave” notice provisions, lawyers in Foley Hoag’s Litigation Department recently secured a favorable outcome for a senior-level financial executive whose former employer sought to block his departure from the company. In a recent ruling by Judge Nathaniel M. Gorton, U.S. District Judge for the District of Massachusetts, the employer’s motion for a preliminary injunction was denied. Partners Michael Boudett and Michael Rosen represented the client, the former head of the Boston office of Bear Stearns. Bear Stearns alleged that the executive violated his employment contract by failing to give 90-days’ notice before departure and by seeking to persuade clients and staff to follow his move to a competitor. In the ruling, Judge Gorton noted that plaintiff’s allegations of misappropriation of confidential information and interference with contractual and business relationships was unsubstantiated. Further, the Foley Hoag team was successful in proving that Bear Stearns would not be subject to irreparable harm with the departure of this executive. Widely covered by national financial media, the case is now pending before an arbitration panel before the Financial Industry Regulatory Association (FINRA). [Read More]
  • HyperBranch Medical Technology, Inc.
    For our client HyperBranch Medical Technology, Inc., a leader in the field of polymeric medical sealants, we assisted with the intellectual property portfolio strategy in connection with obtaining CE Mark designation for the company’s OcuSeal product. OcuSeal is a liquid ocular bandage used to stabilize ocular wounds following surgical or non-surgical trauma. CE Marking denotes that a product complies with all requirements of European health, safety, and environmental product legislation, and is an important step in bringing products to market overseas. HyperBranch began its research in 2004 with the objective to develop strong enough polymer sealants to ultimately replace sutures that would be easy to use, and would not interfere with natural healing. The Durham, North Carolina medical device company has also, been developing advanced surgical sealants for dura (brain), pleural (lung) and hernia mesh fixation. These products are all at various stages of clinical and pre-clinical development. Read more about HyperBranch Medical Technology here. [Read More]